Skip to Main Content

Paper Details

NSD2 is a conserved driver of metastatic prostate cancer progression.
Nat Commun
60
2018
Author NameAffiliation
Joanna Cyrta
Mark A Rubin
Mark A RubinUniversity of Bern
Mark A Rubin
Mark A RubinUniversity of Bern
Andrea CalifanoColumbia University Irving Medical Center
Andrea CalifanoHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center
Andrea CalifanoColumbia University Irving Medical Center
  • 1 - 8

Datasets

Release 1.2